Prospective Study on a Novel Port-site Closure Device (EZ Close): Effectiveness and Comparison With Carter-Thomason

February 13, 2019 updated by: Hee Youn Kim, Saint Vincent's Hospital, Korea

Single Blind Randomized Control Trial Evaluating Efficacy and Safety of EZ-Close Port-site Closure Device Versus Carter-Thomason Device

This study aims to evaluate the efficacy and safety of a novel port-site closure device (EZ Close) by comparing it with the Carter-Thomason device.

Study Overview

Status

Completed

Detailed Description

Port-site closure is a critical procedure after every laparoscopic surgery. Complications such as visceral organ injury, port-site hernia, infection, ascitic fluid leakage may occur during and after the procedure. Many devices were developed and utilized for the procedure and Carter-Thomason is one of the most commonly used device and validated with several studies. This study aims to evaluate the efficacy and safety of a novel port-site closure device (EZ Close) by comparing it with the Carter-Thomason device.

Study Type

Interventional

Enrollment (Actual)

79

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 80 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All patients with laparoscopic ports over 10mm

Exclusion Criteria:

  • Patients with laparoscopic ports under 10mm
  • Patients who refused the study
  • Patients who received concurrent surgery for other reason

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: EZ Close arm
EZ close used for port-site closure.
EZ close used.
ACTIVE_COMPARATOR: Carter Thomason arm
Carter Thomason used for port-site closure.
Carter Thomason used.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time Taken to Complete Closure
Time Frame: At the time of surgery
The start of the procedure was defined as the point when the device was first inserted through the port-site and the end of the procedure was defined as the point when the port-site was removed from the port-site. A stopwatch was used to measure the time.
At the time of surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants With Visceral Organ Injury
Time Frame: At the time of surgery
Any inadvertent injury to organs or bleeding during procedure.
At the time of surgery
Number of Participants With Need for Additional Instrument
Time Frame: At the time of surgery
Need for additional instrument during procedure
At the time of surgery
Number of Participants With Port-site Hernia
Time Frame: 3 days post-op and within one months of surgery
Herniation of bowel segments through port-site
3 days post-op and within one months of surgery
Number of Participants With Port-site Infection
Time Frame: 3 days post-op and within one months of surgery
Redness, purulent discharge, tenderness at port-site
3 days post-op and within one months of surgery
Number of Participants With Ascitic Fluid Leakage
Time Frame: 3 days post-op and within one months of surgery
Non-infective fluid leakage
3 days post-op and within one months of surgery
Number of Participants With Wound Dehiscence
Time Frame: 3 days post-op and within one months of surgery
Wound dehiscence that required further treatment
3 days post-op and within one months of surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hee Youn Kim, St Vincent's Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 17, 2017

Primary Completion (ACTUAL)

May 9, 2018

Study Completion (ACTUAL)

May 24, 2018

Study Registration Dates

First Submitted

December 11, 2017

First Submitted That Met QC Criteria

December 11, 2017

First Posted (ACTUAL)

December 15, 2017

Study Record Updates

Last Update Posted (ACTUAL)

March 1, 2019

Last Update Submitted That Met QC Criteria

February 13, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • EZVSCT

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgical Port Site Hernia

Clinical Trials on EZ close

3
Subscribe